EGFR and gastric cancer: Gastric cancer exhibits alterations in the ErbB receptor family and ErbB-related signalling pathways [55]; in particular, the expression level of ErbB2 is increased in gastric cancer, and ErbB2 targeted therapies for gastric cancer have proved highly beneficial [56].